Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Daiji Yoshikawa"'
Autor:
Takehiro Ito, Daiji Yoshikawa, Mutsuharu Hayashi, Masataka Yoshinaga, Tomoya Ishiguro, Ryo Yamada, Sayano Ueda, Wakaya Fujiwara, Yasuchika Kato, Eiichi Watanabe, Junnichi Ishii, Yukio Ozaki, Hideo Izawa
Publikováno v:
Fujita Medical Journal, Vol 4, Iss 3, Pp 77-81 (2018)
Objectives: There are well-established risk prediction models of in-hospital mortality due to heart failure (HF). However, the predictors of mortality during acute hospitalization in individuals with HF receiving tolvaptan, a vasopressin type 2 recep
Externí odkaz:
https://doaj.org/article/8fc02bbb4d0244dca4800b331ec775c7
Autor:
Hatsumi Inaba, Kyosuke Takeshita, Yasuhiro Uchida, Motoharu Hayashi, Takahiro Okumura, Akihiro Hirashiki, Daiji Yoshikawa, Hideki Ishii, Koji Yamamoto, Takayuki Nakayama, Masaaki Hirayama, Hiroyuki Matsumoto, Tadashi Matsushita, Toyoaki Murohara
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e83977 (2014)
In repetitive measurements of flow-mediated dilatation (FMD), the duration of the interval between measurements remains controversial. In this pilot study, we conducted three sequential measurements of low-flow-mediated constriction (L-FMC), FMD and
Externí odkaz:
https://doaj.org/article/f1bb87042cdd46f899de034d9ef4a4d7
Autor:
Takehiro Ito, Mutsuharu Hayashi, Fumi Yamauchi, Hiroatsu Yokoi, Hideo Izawa, Masataka Yoshinaga, Tomohito Kamada, Wakaya Fujiwara, Junichi Ishii, Yoshinori Sugishita, Daisuke Mukaide, Yukio Ozaki, Manaka Tagaya, Daiji Yoshikawa, Eiichi Watanabe
Publikováno v:
Heart and Vessels. 31:957-962
New oral anticoagulants (NOACs) are now clinically available. However, few studies have demonstrated which patients with non-valvular atrial fibrillation (NVAF) actually receive NOACs in a clinical setting. We analyzed 182 NVAF patients who received
Autor:
Hideki Ishii, Yukio Ozaki, Mutsuharu Hayashi, Akihiro Hirashiki, Ken Harada, Daiji Yoshikawa, Fuji Somura, Tomofumi Mizuno, Takahiro Okumura, Masataka Yoshinaga, Toyoaki Murohara, Tetsuya Amano, Yukihiko Yoshida, Aki Kubota, Junichi Ishii, Shinichi Sakai, Wakaya Fujiwara, Hiroatsu Yokoi, Hideo Izawa
Publikováno v:
International Heart Journal. 56:415-420
Hypertrophic cardiomyopathy (HCM) has various morphological and clinical features. A decade has passed since the previous survey of the epidemiological and clinical characteristics of Japanese HCM patients. The Aichi Hypertrophic Cardiomyopathy (AHC)
Autor:
Takehiro Ito, Wakaya Fujiwara, Yoshinori Sugishita, Yukio Ozaki, Tomohito Kamada, Hiroatsu Yokoi, Daiji Yoshikawa, Hideo Izawa, Daisuke Mukaide, Masataka Yoshinaga, Mutsuharu Hayashi
Publikováno v:
Internal Medicine. 54:31-35
Takotsubo cardiomyopathy is a disorder characterized by left ventricular apical ballooning with preceding emotional and/or physical stressors. This condition is also an important differential diagnosis of acute coronary syndrome. We herein describe a
Autor:
Yasushi Suzuki, Ken Harada, Tetsuya Amano, Hiroshi Takahashi, Akiyoshi Kurita, Hideki Ishii, Tadayuki Uetani, Akihiro Suzuki, Hiroaki Takashima, Tomofumi Mizuno, Toyoaki Murohara, Daiji Yoshikawa, Hirohiko Ando, Soichiro Kumagai, Katsuhisa Waseda
Publikováno v:
EuroIntervention. 10:792-798
AIMS The aim of this study was to address the association of lipid profiles with periprocedural myocardial infarction (pMI) after elective percutaneous coronary intervention (PCI). METHODS AND RESULTS Of the 302 consecutive patients who received elec
Autor:
Yutaka Oiso, Daiji Yoshikawa, Naoki Okumura, Yoshinari Yasuda, Hideki Ishii, Mutsuharu Hayashi, Motomitsu Goto, Toyoaki Murohara, Seiichi Matsuo
Publikováno v:
International Journal of Cardiology. 172:e293-e296
Autor:
Hideki Ishii, Toshimitsu Niwa, Kyosuke Takeshita, Soichiro Kumagai, Susumu Suzuki, Hideo Izawa, Daiji Yoshikawa, Toyoaki Murohara, Mutsuharu Hayashi
Publikováno v:
Circulation Journal. 78:2477-2482
Background:Indoxyl sulfate (IS), a uremic toxin, has cardiovascular as well as uremic toxicity. We evaluated the prognostic value of blood IS level for long-term outcome.Methods and Results:This study followed 311 patients with coronary artery diseas
Autor:
Hideki Ishii, Tetsuya Amano, Mutsuharu Hayashi, Daiji Yoshikawa, Hirohiko Ando, Toyoaki Murohara, Masaya Matsumoto, Satoshi Okumura, Soichiro Kumagai, Miho Tanaka, Yosuke Inoue, Susumu Suzuki
Publikováno v:
International Journal of Cardiology. 167:613-617
systematic review. Circulation 2008;118:1828–36. [28] Kandzari DE, Berger PB, Kastrati A, et al. Influence of treatment durationwith a 600mg dose of clopidogrel before percutaneous coronary revascularization. J Am Coll Cardiol 2004;44:2133–6. [29
Autor:
Toru Aoyama, Tatsuaki Matsubara, Hiroshi Takahashi, Tetsuya Amano, Takanobu Toriyama, Daisuke Kamoi, Tadayuki Uetani, Toyoaki Murohara, Daiji Yoshikawa, Miho Tanaka, Yoshihiro Kawamura, Hideki Ishii, Kazuhiro Kawashima
Publikováno v:
International Journal of Cardiology. 165:533-536
Background Patients on maintenance hemodialysis (HD) are at high risk for restenosis after percutaneous coronary intervention (PCI) even if treated with a sirolimus-eluting stent (SES). The aim of this study was to compare the effects of SES and pacl